Eftilagimod Alpha Novel Triplet Combination is Well Tolerated, Generates CRs in Soft Tissue Sarcoma
Eftilagimod alpha plus radiotherapy and pembrolizumab was safe and displayed initial activity in soft tissue sarcoma.
Source: onclive.com
Eftilagimod Alpha News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Eftilagimod Alpha. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Eftilagimod Alpha Today - Breaking & Trending Today
First Patient Dosed in Trial Evaluating Efti and the Anti-PD-L1 Therapy BAVENCIO® in Metastatic Urothelial Cancer
Media ReleaseSYDNEY, AUSTRALIA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ('Immutep” or “the Company”), a clini...
Source: businessinsider.com
Immutep Reports Promising Clinical Data from INSIGHT-003 Trial at ESMO Congress 2023 -October 24, 2023 at 08:05 am EDT
Media Release Promising efficacy and tolerability reported from efti plus anti-PD-1 therapy and doublet chemotherapy as first line therapy in metastatic non-squamous non-small cell lung cancer...
Source: marketscreener.com
Immutep's Efti in Combination with KEYTRUDA® Generates Excellent Overall Survival Benefit in Patients with Metastatic Non-Small Cell Lung Cancer
Media Release Median Overall Survival reaches 35.5 months in first-line treatment of metastatic non-small cell lung cancer patients expressing PD-L1 (TPS >1%), 23.4 months in patients with low PD-L1 expression (TPS 1-49%), and has not been reached in patients with high PD-L1 expression (TPS >50%), exceeding expectationsPromising Overall Survival, Overall Response Rate, Progression Free Survival, and Duration of Response visible across all PD-L1 subgroups (TPS <1%, ≥1%, 1-49%, and ≥50%), differen
Source: yahoo.com
Immutep Announces Publication of Abstracts at ESMO Congress 2023
Media ReleaseNew updated data from TACTI-002, including more mature Overall Survival data, will be presented during the Mini Oral session on Satur...
Source: businessinsider.com